Penserra Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,210
Closed -$3M 1394
2024
Q1
$3M Buy
+9,210
New +$2.26M 0.04% 297
2023
Q3
Sell
-7,074
Closed -$2.02M 1397
2023
Q2
$2.02M Buy
+7,074
New +$1.96M 0.04% 310
2022
Q4
Sell
-12,732
Closed -$3.54M 1248
2022
Q3
$3.54M Buy
+12,732
New +$3.24M 0.1% 177
2022
Q2
Sell
-10,009
Closed -$2.08M 1538
2022
Q1
$2.08M Buy
+10,009
New +$1.65M 0.05% 336
2021
Q4
Sell
-45,658
Closed -$9.4M 1593
2021
Q3
$9.4M Buy
+45,658
New +$8.96M 0.2% 153

Other funds holding SWAV

Penserra Capital Management's SWAV Position: Q2 2024 in Review

Penserra Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 9,210 shares — an estimated $3M sold.

Penserra Capital Management first reported a position in SWAV in Q3 2021 and held it in 5 quarters. The position peaked at $9.4M in Q3 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Penserra Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Penserra Capital Management sold 9,210 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $3M.
  • Penserra Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Penserra Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $9.4M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Penserra Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.